Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23546520 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
Conditions: Myeloma, Plasma-Cell;   Myeloma-Multiple
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Anti-BCMA CAR T cells

Indicates status has not been verified in more than two years